logo

For the Inventor, By the Inventor

Los Angeles, CA, United States of America

Ritter Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 12

% Expired Patents = 75.0



Forward Citations = 95

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Andrew J Ritter (10 out of 11 patents)

silverMedal David M Barnes (8 out of 34 patents)

bronzeMedal Dennis Savaiano (8 out of 8 patents)

4.  Todd Robert Klaenhammer (8 out of 40 patents)

5.  Giovanni Cipolletti (2 out of 19 patents)

6.  Silvia Giacomelli (2 out of 3 patents)

7.  Marco Manoni (2 out of 6 patents)

8.  Silvia Biagiolini (2 out of 3 patents)

9.  Luana Vagnoli (2 out of 5 patents)

10.  Jacopo Chini (2 out of 5 patents)


12 patents:

1. 11028422 - Process for the production of ultrapure galacto-oligosaccharides (2021-06-08),
2. 9808481 - Prebiotic formulations and methods of use (2017-11-07),
3. 9775860 - Prebiotic formulations and methods of use (2017-10-03),
4. 9592248 - Prebiotic formulations and methods of use (2017-03-14),
5. 9579340 - Prebiotic formulations and methods of use (2017-02-28),
6. 9370532 - Prebiotic formulations and methods of use (2016-06-21),
7. 9226933 - Methods and compositions for treating lactose intolerance (2016-01-05),
8. 9200303 - Process for the production of ultrapure galacto-oligosaccharides (2015-12-01),
9. 8785160 - Prebiotic formulations and methods of use (2014-07-22),
10. 8492124 - Prebiotic formulations and methods of use (2013-07-23),
11. 8486668 - Prebiotic formulations and methods of use (2013-07-16),
12. 7879363 - Method for increasing lactose tolerance in mammals exhibiting lactose intolerance (2011-02-01),
Company Overview
Ritter Pharmaceuticals, Inc. is a biotechnology company based in Los Angeles, California, focused on developing innovative therapies for gastrointestinal diseases. The company specializes in the research and commercialization of novel treatments aimed at improving the quality of life for patients suffering from lactose intolerance and other related conditions. By leveraging advanced scientific methodologies, Ritter Pharmaceuticals aims to address unmet medical needs in the digestive health sector, contributing to the evolving landscape of gastrointestinal therapeutics.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

12 Patents

#167 in Los Angeles, CA

#6,069 in California

#25,589 in US

#48,235 in the World

Los Angeles, CA (US)
Los Angeles, CA, United States of America

Ritter Pharmaceuticals, Inc.

Forward Citations = 95

10 inventors:

goldMedal Andrew J Ritter (10 out of 11 patents)

silverMedal David M Barnes (8 out of 34 patents)

bronzeMedal Dennis Savaiano (8 out of 8 patents)

4.  Todd Robert Klaenhammer (8 out of 40 patents)

5.  Giovanni Cipolletti (2 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ritter Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/ritter-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…